MAPT and Alzheimer disease: Apart from that, cross-sectional studies covering the entire clinical AD continuum have revealed that plasma isoforms p-tau181 and p-tau217 may distinguish amyloid-PET or tau-PET positive cases from amyloid-PET or tau-PET negative cases.